[Emphasis on scientific research related to viral hepatitis]

The Chinese Journal of Hepatology second supplementary issue in 2024 focused on viral hepatitis. The context of hepatitis B and C encompassed the exploration of expanding treatment advantages, research on the treatment of special populations, the clinical cure concept, and the regional and special population genotyping, treatment of patients who failed to receive direct-acting antiviral drugs, and medical prevention and elimination fusion models. The supplement's findings reflect the current trends in prevention and treatment, such as epidemiology, clinical practice, and elimination models, and serve as references for exploring antiviral treatment plans and hepatitis elimination models, assisting readers to experience the academic dynamism of liver disease, address elimination challenges, and facilitate goal attainment.